{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:20:00Z","timestamp":1792120800043,"version":"4.4.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.humpath.2022.10.005","type":"journal-article","created":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T13:01:25Z","timestamp":1665666085000},"page":"47-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Lymphoplasmacytic lymphoma with IgG or IgA paraprotein: a study of 29 cases including cases that can mimic plasma cell neoplasms"],"prefix":"10.1016","volume":"130","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4218-4587","authenticated-orcid":false,"given":"Lianqun","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Okechukwu V.","family":"Nwogbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beenu","family":"Thakral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. James","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres E.","family":"Quesada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Bueso","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"McDonnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheeba K.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2022.10.005_bib1","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2022.10.005_bib2","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1111\/bjh.18002","article-title":"Clinical characteristic and outcome of lymphoplasmacytic lymphoma of non-Waldenstrom macroglobulinemia type: a Swedish lymphoma registry study","volume":"196","author":"Brandefors","year":"2022","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2022.10.005_bib3","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.3109\/10428194.2015.1096357","article-title":"Clinicopathologic features and outcomes of lymphoplasmacytic lymphoma patients with monoclonal IgG or IgA paraprotein expression","volume":"57","author":"Cao","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.humpath.2022.10.005_bib4","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/cyto.b.21083","article-title":"Potential therapeutic biomarkers in plasma cell myeloma: a flow cytometry study","volume":"84","author":"Zheng","year":"2013","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1016\/j.humpath.2022.10.005_bib5","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/modpathol.2015.66","article-title":"Clinical significance of newly emerged isolated del(20q) in patients following cytotoxic therapies","volume":"28","author":"Yin","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2022.10.005_bib6","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000516654","article-title":"International system for human cytogenetic or cytogenomic nomenclature (ISCN): some thoughts","volume":"161","author":"Liehr","year":"2021","journal-title":"Cytogenet Genome Res"},{"key":"10.1016\/j.humpath.2022.10.005_bib7","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1038\/modpathol.2017.93","article-title":"Increased MYC copy number is an independent prognostic factor in patients with diffuse large B-cell lymphoma","volume":"30","author":"Quesada","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2022.10.005_bib8","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.clml.2016.04.014","article-title":"Clinical validation of a CXCR4 mutation screening assay for Waldenstrom macroglobulinemia","volume":"16","author":"Ballester","year":"2016","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.humpath.2022.10.005_bib9","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/bjh.15877","article-title":"Routine sequencing in CLL has prognostic implications and provides new insight into pathogenesis and targeted treatments","volume":"185","author":"Hu","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2022.10.005_bib10","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/ajcp\/aqw072","article-title":"Lymphoplasmacytic lymphoma with a non-IgM paraprotein shows clinical and pathologic heterogeneity and may harbor MYD88 L265P mutations","volume":"145","author":"King","year":"2016","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2022.10.005_bib11","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/ajh.25600","article-title":"Clinical and molecular characteristics of lymphoplasmacytic lymphoma not associated with an IgM monoclonal protein: a multicentric study of the Rete Ematologica Lombarda (REL) network","volume":"94","author":"Varettoni","year":"2019","journal-title":"Am J Hematol"},{"key":"10.1016\/j.humpath.2022.10.005_bib12","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1080\/10428194.2020.1719100","article-title":"A matched case-control study comparing features, treatment and outcomes between patients with non-IgM lymphoplasmacytic lymphoma and Waldenstrom macroglobulinemia","volume":"61","author":"Castillo","year":"2020","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.humpath.2022.10.005_bib13","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.pathol.2019.09.009","article-title":"Lymphoplasmacytic lymphoma and Waldenstrom macroglobulinaemia: clinicopathological features and differential diagnosis","volume":"52","author":"Wang","year":"2020","journal-title":"Pathology"},{"key":"10.1016\/j.humpath.2022.10.005_bib14","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1182\/blood.V99.6.2185","article-title":"Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation","volume":"99","author":"Avet-Loiseau","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2022.10.005_bib15","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1309\/3G1XDX0DVHBNVKB4","article-title":"Immunophenotypic profile of lymphoplasmacytic lymphoma\/Waldenstrom macroglobulinemia","volume":"124","author":"Konoplev","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2022.10.005_bib16","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/bjh.13303","article-title":"Immunophenotypic features by multiparameter flow cytometry can help distinguish low grade B-cell lymphomas with plasmacytic differentiation from plasma cell proliferative disorders with an unrelated clonal B-cell process","volume":"169","author":"Rosado","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2022.10.005_bib17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1309\/AJCP8FOIVTB6LBER","article-title":"Lymphoplasmacytic lymphoma and other non-marginal zone lymphomas with plasmacytic differentiation","volume":"136","author":"Lin","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2022.10.005_bib18","first-page":"10","article-title":"Concomitant lymphoplasmacytic lymphoma and plasma cell myeloma, a diagnostic challenge","volume":"7","author":"Mansour","year":"2017","journal-title":"Am J Blood Res"},{"key":"10.1016\/j.humpath.2022.10.005_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.5769","article-title":"Concomitant lymphoplasmacytic lymphoma, multiple myeloma, and amyloidosis: a diagnostic and therapeutic challenge","volume":"10","author":"Ceballos","year":"2022","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.humpath.2022.10.005_bib20","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.humpath.2011.11.001","article-title":"Concomitant Waldenstrom macroglobulinemia and IgA plasmablastic myeloma in a patient with untreated IgM paraproteinemia: sequential development of biclonal B-cell neoplasms over a 10-year period in a single individual","volume":"43","author":"Wang","year":"2012","journal-title":"Hum Pathol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817722002441?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817722002441?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:40:15Z","timestamp":1758645615000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817722002441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":20,"alternative-id":["S0046817722002441"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2022.10.005","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lymphoplasmacytic lymphoma with IgG or IgA paraprotein: a study of 29 cases including cases that can mimic plasma cell neoplasms","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2022.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}